Lv32
294 积分 2023-05-06 加入
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
1天前
待确认
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
1天前
已完结
Global Lung Function Initiative reference values for multiple breath washout indices
9天前
已关闭
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
9天前
已完结
Effectiveness of Interventions Targeting Treatable Traits for the Management of Obstructive Airway Diseases: A Systematic Review and Meta-Analysis
20天前
已完结
Alveolar nitric oxide and asthma control in mild untreated asthma
21天前
已完结
COPD‐X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update
21天前
已完结
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
21天前
已完结
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience
1个月前
已完结
Chronic obstructive pulmonary disease
1个月前
已完结
皖公网安备34019202002308
